January 4, 2018 / 5:13 AM / Updated an hour ago BRIEF-Arvinas announces research collaboration and license agreement with Pfizer Inc Reuters Staff 1 Min Read 
Jan 4 (Reuters) - Arvinas LLC: 
* ARVINAS ANNOUNCES RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH PFIZER INC. FOR THE DISCOVERY AND DEVELOPMENT OF PROTEIN DEGRADATION DRUG CANDIDATES 
* ANNOUNCED A RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH PFIZER INC​ 
* ARVINAS SAYS MAY RECEIVE UP TO $830 MILLION IN UPFRONT AND POTENTIAL DEVELOPMENT AND COMMERCIALIZATION MILESTONE PAYMENTS UPON ACHIEVEMENT OF SPECIFIED MILESTONES​ 
* ‍CO MAY BE ENTITLED TO RECEIVE TIERED ROYALTIES BASED ON GLOBAL PRODUCT SALES ON ANY PRODUCTS THAT MAY RESULT FROM COLLABORATION​ Source text for Eikon: Further company coverage: